These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 10620555

  • 1. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica.
    Escribá A, Morales E, Albizúa E, Herrero JC, Ortuño T, Carreño A, Dominguez-Gil B, Praga M.
    Am J Kidney Dis; 2000 Jan; 35(1):137-40. PubMed ID: 10620555
    [Abstract] [Full Text] [Related]

  • 2. Giant cell arteritis and renal amyloidosis: report of a case.
    Moraga, Sicilia JJ, Blanco J, Ubeda I.
    Clin Nephrol; 2001 Nov; 56(5):402-6. PubMed ID: 11758014
    [Abstract] [Full Text] [Related]

  • 3. Secondary amyloidosis associated with giant cell arteritis/polymyalgia rheumatica.
    Stebbing J, Buetens O, Hellmann D, Stone J.
    J Rheumatol; 1999 Dec; 26(12):2698-700. PubMed ID: 10606387
    [Abstract] [Full Text] [Related]

  • 4. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA, García-Porrúa C, Vázquez-Caruncho M.
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [Abstract] [Full Text] [Related]

  • 5. Rapid development of renal failure secondary to AA-type amyloidosis in a patient with polymyalgia rheumatica.
    Javaid MM, Kamalanathan M, Kon SP.
    J Ren Care; 2010 Dec; 36(4):199-202. PubMed ID: 20969738
    [Abstract] [Full Text] [Related]

  • 6. Giant cell (temporal) arteritis and secondary renal amyloidosis: report of 2 cases.
    Monteagudo M, Vidal G, Andreu J, Oristrell J, Tolosa C, Larrosa M, Casanovas A, Almirall J.
    J Rheumatol; 1997 Mar; 24(3):605-7. PubMed ID: 9058675
    [Abstract] [Full Text] [Related]

  • 7. Amyloidosis and giant cell arteritis/polymyalgia rheumatica.
    Legault K, Shroff A, Crowther M, Khalidi N.
    J Rheumatol; 2012 Apr; 39(4):878-80. PubMed ID: 22467956
    [No Abstract] [Full Text] [Related]

  • 8. Giant cell arteritis "causing" AA-amyloidosis with rapid renal failure.
    Strasser F, Hailemariam S, Weinreich T, Speich R, Salomon F.
    Schweiz Med Wochenschr; 2000 Oct 28; 130(43):1606-9. PubMed ID: 11100514
    [Abstract] [Full Text] [Related]

  • 9. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?
    Espinosa G, Font J, Muñoz-Rodríguez FJ, Cervera R, Ingelmo M.
    Clin Rheumatol; 2002 Aug 28; 21(4):309-13. PubMed ID: 12189460
    [Abstract] [Full Text] [Related]

  • 10. [Primary systemic amyloidosis presenting as polymyalgia rheumatica and giant cell arteritis].
    Pantoja Zarza L, Paniagua De La Riva J, Megido Lahera M, Ortiz De Saracho J.
    An Med Interna; 2001 Apr 28; 18(4):205-7. PubMed ID: 11496541
    [Abstract] [Full Text] [Related]

  • 11. [Rheumatic polymyalgia and temporal arteritis. Case contribution and bibliographic review].
    Manganelli P, Mercadanti M, Nervetti A, Ambanelli U.
    Minerva Med; 1987 Mar 15; 78(5):287-96. PubMed ID: 3822219
    [Abstract] [Full Text] [Related]

  • 12. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
    Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG.
    J Rheumatol; 1995 Sep 15; 22(9):1694-7. PubMed ID: 8523347
    [Abstract] [Full Text] [Related]

  • 13. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.
    Rheumatology (Oxford); 2003 Sep 15; 42(9):1055-61. PubMed ID: 12730520
    [Abstract] [Full Text] [Related]

  • 14. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
    Narváez J, Bernad B, Díaz Torné C, Momplet JV, Montpel JZ, Nolla JM, Valverde-García J.
    J Rheumatol; 2006 Jul 15; 33(7):1293-8. PubMed ID: 16783861
    [Abstract] [Full Text] [Related]

  • 15. A rare cause of AA amyloidosis and end-stage kidney failure: Answers.
    Taşdemir M, Yılmaz S, Baba ZF, Bilge I.
    Pediatr Nephrol; 2019 Sep 15; 34(9):1537-1539. PubMed ID: 30456664
    [No Abstract] [Full Text] [Related]

  • 16. [Polymyalgia rheumatica and giant cell arteritis].
    Jipp P, Fehring K.
    Dtsch Med Wochenschr; 1984 Oct 26; 109(43):1635-8. PubMed ID: 6489177
    [Abstract] [Full Text] [Related]

  • 17. Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor.
    Agha I, Mahoney R, Beardslee M, Liapis H, Cowart RG, Juknevicius I.
    Am J Kidney Dis; 2002 Aug 26; 40(2):411-5. PubMed ID: 12148117
    [Abstract] [Full Text] [Related]

  • 18. Giant cell arteritis and secondary amyloidosis: the natural history.
    Altiparmak MR, Tabak F, Pamuk ON, Pamuk GE, Mert A, Aktuğlu Y.
    Scand J Rheumatol; 2001 Aug 26; 30(2):114-6. PubMed ID: 11324788
    [Abstract] [Full Text] [Related]

  • 19. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N, Fritz P, Rieth A, Schroth W, Kimmel M, Biegger D, Zakim D, Alscher MD.
    J Rheumatol; 2009 Oct 26; 36(10):2269-76. PubMed ID: 19684157
    [Abstract] [Full Text] [Related]

  • 20. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
    Mattey DL, Hajeer AH, Dababneh A, Thomson W, González-Gay MA, García-Porrúa C, Ollier WE.
    Arthritis Rheum; 2000 Aug 26; 43(8):1749-55. PubMed ID: 10943865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.